CONTINUE TO SITE
OR WAIT 15 SECS
Bayer and Tsinghua University (THU) have announced the signing of the sixth phase of the collaboration agreeme
Japan-based NEC Corporation, in collaboration with Chugai Pharmaceutical Co., has conducted an exper
AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals G
A research team led by Dr Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in colla
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven pr
Administered through the National Health and Medical Research Council’s (NHMRC) Clinical Trials and
Alcon, the global leader in eye care, has announced the official opening of its expanded state-of-the-art manu
German firm Covestro has launched production of its new Desmopan® Rx medical-grade Thermoplastic Polyureth
AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1, 20
Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in sev
APAC'S ALLIANCE-DRIVEN BIOTECH BOOM
Partnerships are a cornerstone of the biotech innovation process. COVID-19 acted as a catalyst, accelerating collaboration across the sector and prompting partnerships between established players for the first time. Since then, biotech alliances have become more diverse, frequent, and strategically important, especially in the Asia-Pacific (APAC) region. Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique geopolitical and socio-economic landscape of the region. The region has innovation hubs like Japan and South Korea as well as large, high-growth markets such as China and India. As China rapidly scales its biopharma capabilities, it is becoming both a key market and an innovator. This transformation has redefined regional deal-making, shifting the focus from technology transfer to co-development, shared commercialisation, and strategic alignment. APAC biotech deals are no longer early-stage R&D plays, they are beginning to span the full lifecycle, from bench to bedside, including commercialisation milestones. Let’s explore further the APAC's wave of regional biotech partnerships during the first five months of this calendar year ie. from January to May 2025.
Precision In Clinical Trials Summit Europe 2025
Precison Evolution Global
info@precision-globe.com https://events.precision-globe.com/single-event/precision-clinical-trials-summit-Zurich-europeInn Zurich, Switzerland
MICRO-NANO PLASTICS IN WATE
ECI
eci@informz.net https://engconf.us/conferences/civil-and-environmental-engineering/microplastics-in-water-characterization-cure-and-prevention/Davos, Switzerland
